ID

41189

Beschrijving

BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT01562028

Link

https://clinicaltrials.gov/show/NCT01562028

Trefwoorden

Versies (1)
  1. 08-07-20 08-07-20 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

8 juli 2020

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Lung Cancer NCT01562028

Engels

Eligibility Lung Cancer NCT01562028

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
age ≥ 18 years
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
ecog performance status 0-2
Beschrijving

ECOG performance status

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
adequate haematological function, coagulation, liver function and renal function
Beschrijving

Hematologic function | Coagulation function analysis | Liver function | Renal function

Datatype

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C3516400
UMLS CUI [3]
C0232741
UMLS CUI [4]
C0232804
pathological diagnosis of predominantly non-squamous, non-small-cell lung cancer (nsclc)
Beschrijving

Non-squamous non-small cell lung cancer

Datatype

boolean

Alias
UMLS CUI [1]
C4324656
tnm version 7 stage iv disease including m1a (malignant effusion) or m1b (distant metastasis), or locally advanced disease not amenable to curative treatment (including patients progressing after radiochemotherapy for stage iii disease)
Beschrijving

Disease TNM clinical staging | Advanced disease Locally | Disease Inappropriate Curative treatment | Disease Progression | Status post Chemoradiotherapy Disease TNM clinical staging

Datatype

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C3258246
UMLS CUI [2,1]
C0679246
UMLS CUI [2,2]
C1517927
UMLS CUI [3,1]
C0012634
UMLS CUI [3,2]
C1548788
UMLS CUI [3,3]
C1273390
UMLS CUI [4]
C0242656
UMLS CUI [5,1]
C0231290
UMLS CUI [5,2]
C0436307
UMLS CUI [5,3]
C0012634
UMLS CUI [5,4]
C3258246
measurable or evaluable disease (according to recist 1.1 criteria).
Beschrijving

Measurable Disease | Evaluable Disease

Datatype

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C1516986
centrally confirmed egfr exon 19 deletion (del19) or exon 21 mutation (l858r)
Beschrijving

EGFR exon 19 deletion | EGFR Exon 21 Mutation

Datatype

boolean

Alias
UMLS CUI [1]
C3889117
UMLS CUI [2]
C4289654
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with increased risk of bleeding
Beschrijving

High risk of bleeding

Datatype

boolean

Alias
UMLS CUI [1]
C4039184
patients with clinically significant cardiovascular diseases
Beschrijving

Cardiovascular Disease

Datatype

boolean

Alias
UMLS CUI [1]
C0007222
patients with a history of thrombosis or thromboembolism in the 6 months prior to treatment
Beschrijving

Thrombosis | Thromboembolism

Datatype

boolean

Alias
UMLS CUI [1]
C0040053
UMLS CUI [2]
C0040038
patients with gastrointestinal problems
Beschrijving

Gastrointestinal problem

Datatype

boolean

Alias
UMLS CUI [1]
C0017187
patients with neurologic problems
Beschrijving

Nervous system problem

Datatype

boolean

Alias
UMLS CUI [1]
C0221571
C0154091 patients who have had in the past 5 years any previous or concomitant malignancy except adequately treated basal or squamous cell carcinoma of the skin, in situ carcinoma of the cervix or bladder, in situ breast carcinoma.
Beschrijving

Malignant Neoplasm | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Exception Carcinoma in situ of uterine cervix Treated | Exception Carcinoma in situ of bladder Treated | Exception Carcinoma in situ of female breast Treated

Datatype

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007117
UMLS CUI [2,3]
C1522326
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0553723
UMLS CUI [3,3]
C1522326
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0851140
UMLS CUI [4,3]
C1522326
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0154091
UMLS CUI [5,3]
C1522326
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C0686288
UMLS CUI [6,3]
C1522326
patients with any known significant ophthalmologic anomaly of the ocular surface
Beschrijving

Anomaly of eye Surface of eye

Datatype

boolean

Alias
UMLS CUI [1,1]
C4076038
UMLS CUI [1,2]
C4321570
patients who received prior chemotherapy for metastatic disease
Beschrijving

Prior Chemotherapy Neoplasm Metastasis

Datatype

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0027627
patients who received previous treatment for lung cancer with drugs targeting egfr or vegf
Beschrijving

Prior Therapy Malignant neoplasm of lung | EGFR targeted therapy | VEGF targeted therapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0242379
UMLS CUI [2]
C4733187
UMLS CUI [3]
C4733192
pregnancy
Beschrijving

Pregnancy

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
Terug naar het begin van de pagina

Similar models

Eligibility Lung Cancer NCT01562028

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Hematologic function | Coagulation function analysis | Liver function | Renal function
Item
adequate haematological function, coagulation, liver function and renal function
boolean
C0221130 (UMLS CUI [1])
C3516400 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
C0232804 (UMLS CUI [4])
Non-squamous non-small cell lung cancer
Item
pathological diagnosis of predominantly non-squamous, non-small-cell lung cancer (nsclc)
boolean
C4324656 (UMLS CUI [1])
Disease TNM clinical staging | Advanced disease Locally | Disease Inappropriate Curative treatment | Disease Progression | Status post Chemoradiotherapy Disease TNM clinical staging
Item
tnm version 7 stage iv disease including m1a (malignant effusion) or m1b (distant metastasis), or locally advanced disease not amenable to curative treatment (including patients progressing after radiochemotherapy for stage iii disease)
boolean
C0012634 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C0679246 (UMLS CUI [2,1])
C1517927 (UMLS CUI [2,2])
C0012634 (UMLS CUI [3,1])
C1548788 (UMLS CUI [3,2])
C1273390 (UMLS CUI [3,3])
C0242656 (UMLS CUI [4])
C0231290 (UMLS CUI [5,1])
C0436307 (UMLS CUI [5,2])
C0012634 (UMLS CUI [5,3])
C3258246 (UMLS CUI [5,4])
Measurable Disease | Evaluable Disease
Item
measurable or evaluable disease (according to recist 1.1 criteria).
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
EGFR exon 19 deletion | EGFR Exon 21 Mutation
Item
centrally confirmed egfr exon 19 deletion (del19) or exon 21 mutation (l858r)
boolean
C3889117 (UMLS CUI [1])
C4289654 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
High risk of bleeding
Item
patients with increased risk of bleeding
boolean
C4039184 (UMLS CUI [1])
Cardiovascular Disease
Item
patients with clinically significant cardiovascular diseases
boolean
C0007222 (UMLS CUI [1])
Thrombosis | Thromboembolism
Item
patients with a history of thrombosis or thromboembolism in the 6 months prior to treatment
boolean
C0040053 (UMLS CUI [1])
C0040038 (UMLS CUI [2])
Gastrointestinal problem
Item
patients with gastrointestinal problems
boolean
C0017187 (UMLS CUI [1])
Nervous system problem
Item
patients with neurologic problems
boolean
C0221571 (UMLS CUI [1])
Malignant Neoplasm | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Exception Carcinoma in situ of uterine cervix Treated | Exception Carcinoma in situ of bladder Treated | Exception Carcinoma in situ of female breast Treated
Item
C0154091 patients who have had in the past 5 years any previous or concomitant malignancy except adequately treated basal or squamous cell carcinoma of the skin, in situ carcinoma of the cervix or bladder, in situ breast carcinoma.
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0553723 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0851140 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
C1705847 (UMLS CUI [5,1])
C0154091 (UMLS CUI [5,2])
C1522326 (UMLS CUI [5,3])
C1705847 (UMLS CUI [6,1])
C0686288 (UMLS CUI [6,2])
C1522326 (UMLS CUI [6,3])
Anomaly of eye Surface of eye
Item
patients with any known significant ophthalmologic anomaly of the ocular surface
boolean
C4076038 (UMLS CUI [1,1])
C4321570 (UMLS CUI [1,2])
Prior Chemotherapy Neoplasm Metastasis
Item
patients who received prior chemotherapy for metastatic disease
boolean
C1514457 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
Prior Therapy Malignant neoplasm of lung | EGFR targeted therapy | VEGF targeted therapy
Item
patients who received previous treatment for lung cancer with drugs targeting egfr or vegf
boolean
C1514463 (UMLS CUI [1,1])
C0242379 (UMLS CUI [1,2])
C4733187 (UMLS CUI [2])
C4733192 (UMLS CUI [3])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial